Rabbit Anti-TMBIM1 Polyclonal Antibody

Referencia HPA070824

embalaje : 100ul

Marca : Atlas Antibodies

Contact local distributor :


Teléfono : +1 850 650 7790

HPA070824
transmembrane BAX inhibitor motif containing 1

Anti-TMBIM1 Antibody

Polyclonal Antibody against HUMAN TMBIM1

0.05 mg/ml
info@quimigen.pt

Immunofluorescent staining of human cell line HaCaT shows localization to vesicles.

Product details

  • Target protein: transmembrane BAX inhibitor motif containing 1
  • Target gene: TMBIM1
  • Verified species reactivity: Human
  • Interspecies information: Highest antigen sequence indentity to the following orthologs: MOUSE - ENSMUSG00000006301 (90%)RAT - ENSRNOG00000014797 (86%)
  • Clonality: Polyclonal
  • Isotype: IgG
  • Host: Rabbit
  • Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
    Material Safety Data Sheet
  • Purification method: Affinity purified using the PrEST antigen as affinity ligand
  • Antigen sequence: Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence
  • Notes: Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user.

Current lot

  • Unit size: 100µl
  • Current lot: R100365
  • Concentration: 0.05 mg/ml

Applications

  • Immunofluorescence in Cell Lines (ICC-IF) recommended conditions
    • Working concentration: 0.25-2 µg/ml
    • Fixation/Permeabilization: PFA/Triton X-100

Validation

  • Immunofluorescence in Cell Lines (ICC-IF) 

Target information

  • Protein name: transmembrane BAX inhibitor motif containing 1
  • Gene name: TMBIM1
  • Alternative gene names: LFG3, PP1201, RECS1, 
  • Ensembl: 
  • Entrez: 
  • UniProt: 

Shipping and storage

  • Shipping: Normally shipped at ambient temperatureStorage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

References (1)

  • This antibody has been used for staining of 44 normal human tissue samples as well as human cancer samples covering the 20 most common cancer types and up to 12 patients for each cancer type. The results are part of an ongoing effort to map the human proteome using antibodies.
    Human Protein Atlas